Pharmacy Channel Intelligence  ·  Australia

What actually happens
at the dispensing counter.

MAP Consultancy gives pharma and biotech companies direct access to how the pharmacy channel works — from someone who works in it every week. Grounded in real dispensing behaviour, not desk research.

Start a conversation See what we do →
Scroll
Services

Six ways MAP
can help your team.

From launch strategy to HCP training — every service is built on active pharmacy practice, not theory.

01
Launch Intelligence
Pharmacy channel strategy, competitive landscape assessment, wholesaler and banner group dynamics, and pharmacy program design and evaluation.
02
Promotional & Medical Review
Independent review of promotional materials and medical communications through a practising community pharmacist lens.
03
HCP Engagement & Speaking
Training content development and delivery for sales and medical teams. Call flow design, rep engagement guidance, and pharmacist education programs.
04
Biosimilar Switch Strategy
Analysis of substitution behaviour and switch drivers at the dispensing level. Program design to understand and accelerate biosimilar uptake in pharmacy.
05
Pharmacy Program Design & Audit
Practical design and independent review of pharmacy support programs — assessed against real-world dispensing workflow and pharmacist adoption behaviour.
06
Pharmacist Advisory & KOL Engagement
Identification and briefing of community pharmacist key opinion leaders for advisory boards, market research programs, and speaker engagements.
Why MAP

The insight is
current and first-hand.

Still dispensing
Active community pharmacist every week — not a former pharmacist turned consultant. The insight is current, first-hand, and grounded in what's actually happening at the counter right now.
Industry + practice
Blue-chip pharma industry background combined with frontline community pharmacy. Both the strategic view and the operational reality — from both sides of the counter.
Channel-first thinking
Advice built from real substitution decisions, program adoption behaviour, and dispensing economics. Not desk research — real intelligence from inside the channel.
Proven delivery
Completed engagements for a global pharma obesity launch and a specialty biosimilar market entry in Australia — with Medical Affairs and Brand teams at major pharma companies.
Selected Projects

Work that has
moved the needle.

Three engagements across obesity, biosimilars, and women's health — 2024 to 2026.

Global Top-5 Pharma
Obesity Division · 2024
Launch Strategy & HCP Training
Training content development, pharmacist engagement strategy, rep call flow design, and frontline team training delivered at national sales bootcamp.
HCP Engagement  ·  Launch Intelligence
Specialty Pharma
Biosimilars · 2026
Pharmacy Channel Market Assessment
Full competitive analysis covering wholesaler pricing, banner group alignment, pharmacy program mechanics, and launch positioning strategy.
Launch Intelligence  ·  Market Assessment
Consumer Healthcare
Women's Health · 2024
HCP Training Content Development
Development and delivery of pharmacist training video content for product education and in-pharmacy HCP engagement.
HCP Engagement  ·  Medical Education
Companies worked with
novonordisk
Pharmaceuticals
CELLTRION
Healthcare Australia
perrigo
Consumer Healthcare
MSD
Australia
Engagements across pharma and consumer healthcare — Medical Affairs, Brand, and commercial teams.
Therapeutic Expertise

Across the full
pharmacy spectrum.

Active across the full breadth of community pharmacy — from chronic disease management to acute care and specialist medicines.

Every
dispensing
decision
Obesity &
Weight Management
Osteoporosis &
Bone Health
Women's
Health
Biosimilars &
Biologics
Cardiovascular &
Hypertension
Diabetes &
Metabolic
Mental Health &
Neurology
Pain
Management
Respiratory &
Allergy
Oncology
Support
Chronic Disease
Management
Acute Care &
Infection
Get in touch

Let's talk about
what you're working on.

Email
mert@mapconsultancy.com.au
Phone
0413 276 716
Based in
Australia
ABN
54 858 206 624
Available for project-based and retainer engagements. Scope and fees discussed on enquiry. Buyers include Medical Affairs Managers, Brand and Marketing Managers, and Country GMs at pharma and biotech companies operating in Australia.